Related Articles
Cisplatin combined with laser‑activated nanotherapy as an adjuvant therapy for head and neck cancer
A REPORT ON THE COMPARATIVE RESPONSE OF SHEEP EPIDERMAL SQUAMOUS-CELL CARCINOMA TO INTRAARTERIAL VERSUS INTRAVENOUS CISPLATIN INFUSION
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models
Epigenetic editing and tumor‑dependent immunosuppressive signaling in head and neck malignancies (Review)
Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer